GB2248774A - Mattress or cushion having biocidal cover - Google Patents
Mattress or cushion having biocidal cover Download PDFInfo
- Publication number
- GB2248774A GB2248774A GB9124357A GB9124357A GB2248774A GB 2248774 A GB2248774 A GB 2248774A GB 9124357 A GB9124357 A GB 9124357A GB 9124357 A GB9124357 A GB 9124357A GB 2248774 A GB2248774 A GB 2248774A
- Authority
- GB
- United Kingdom
- Prior art keywords
- mattress
- fabric
- cover
- coating
- bacteriostat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003115 biocidal effect Effects 0.000 title claims description 28
- 238000000576 coating method Methods 0.000 claims abstract description 30
- 239000011248 coating agent Substances 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000003899 bactericide agent Substances 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 239000004744 fabric Substances 0.000 claims description 45
- 239000000126 substance Substances 0.000 claims description 16
- 239000006260 foam Substances 0.000 claims description 12
- 230000035699 permeability Effects 0.000 claims description 6
- 239000003063 flame retardant Substances 0.000 claims description 4
- 239000011527 polyurethane coating Substances 0.000 claims description 4
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 claims 1
- 210000004712 air sac Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- 239000002585 base Substances 0.000 description 9
- 239000004599 antimicrobial Substances 0.000 description 6
- 239000003139 biocide Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 239000010457 zeolite Substances 0.000 description 5
- 229910021536 Zeolite Inorganic materials 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000000845 anti-microbial effect Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 4
- 239000000428 dust Substances 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000008199 coating composition Substances 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 206010011409 Cross infection Diseases 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- VGVRPFIJEJYOFN-UHFFFAOYSA-N 2,3,4,6-tetrachlorophenol Chemical class OC1=C(Cl)C=C(Cl)C(Cl)=C1Cl VGVRPFIJEJYOFN-UHFFFAOYSA-N 0.000 description 1
- XBILVINOJVKEHG-UHFFFAOYSA-N 2-chloro-6-phenylphenol Chemical compound OC1=C(Cl)C=CC=C1C1=CC=CC=C1 XBILVINOJVKEHG-UHFFFAOYSA-N 0.000 description 1
- MCONGYNHPPCHSD-UHFFFAOYSA-N 3-dimethoxyphosphoryl-n-(hydroxymethyl)propanamide Chemical compound COP(=O)(OC)CCC(=O)NCO MCONGYNHPPCHSD-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- PSWOBQSIXLVPDV-CXUHLZMHSA-N chembl2105120 Chemical compound C1=C(O)C(OC)=CC(\C=N\NC(=O)C=2C=CN=CC=2)=C1 PSWOBQSIXLVPDV-CXUHLZMHSA-N 0.000 description 1
- BSBSDQUZDZXGFN-UHFFFAOYSA-N cythioate Chemical compound COP(=S)(OC)OC1=CC=C(S(N)(=O)=O)C=C1 BSBSDQUZDZXGFN-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- -1 tin sulphosalicylate Chemical compound 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47C—CHAIRS; SOFAS; BEDS
- A47C27/00—Spring, stuffed or fluid mattresses or cushions specially adapted for chairs, beds or sofas
- A47C27/002—Mattress or cushion tickings or covers
- A47C27/005—Mattress or cushion tickings or covers liquid-impermeable
- A47C27/006—Mattress or cushion tickings or covers liquid-impermeable breathable
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47C—CHAIRS; SOFAS; BEDS
- A47C31/00—Details or accessories for chairs, beds, or the like, not provided for in other groups of this subclass, e.g. upholstery fasteners, mattress protectors, stretching devices for mattress nets
- A47C31/007—Anti-mite, anti-allergen or anti-bacterial means
Landscapes
- Mattresses And Other Support Structures For Chairs And Beds (AREA)
Abstract
A mattress or cushion cover is provided in which the cover comprises a sheet material which is permeable to water- vapour but substantially impermeable to liquid water, said sheet material having a bacteriostat or bactericidal substance incorporated within the material or contained in a coating on the inner surface.
Description
MATTRESS OR CUSHION HAVING BIOCInAL CO1YXE This invention relates to a mattress or cushion having a biocidal cover and to covers for such use.
It is a constant problem, particularly in the environment of hospitals and nursing homes, to maintan a high degree of hygiene and sterility in mattresses and cushions in order to prevent cross-infection when beds are used by successive patients. Current procedures involve the use of disposable mattress covers or waterproof mattress covers which are washed with disinfectant before a bed is occupied by a new patient. The former solution is expensive, while the second does not always maintain bacteriostatic conditions within the cover.
A further measure which is sometimes taken is to subject covers to auto-claving in order to destroy the bacteria by heat sterilisation. Apart fro being an expensive and laborious procedure, some materials do not easily withstand the temperatures involved in auto-claving treatment or are degraded by such treatment so that their useful life is shortened. Moreover, autoclaving does net guarantee that sterile conditions can be maintained over a sufficient period of use.
According to one aspect of the present invention, there is provided a mattress or cushion wherein the cover comprises a sheet material which is permeable to watervapour but substantially impermeable to liquid water, said sheet material having a bacteriostat or bacterial substance incorporated within the material or contained in a coating on the inner surface.
The invention is based on the realisation that bacteria tend to migrate from an area of initial infection on droplets of water and/or microscopic particles of dust.
When a person is resting in a bed, moisture from perspiration and other body fluids becomes trapped between the body and the supporting surf ace. In cases where the mattress or pillow cover is water-vapour permeable, watervapour passes through the cover to the interior because the water-vapour pressure is higher on the outside surface in the region between the patient and the surface, thus making the patient more comfortable. As water-vapour permeable fabrics or materials can be microporous, it is thought that bacteria will be carried through the fabric of the cover and this would lead to a spread of infection throughout the mattress or pillow. By incorporating a bacteriostat or bactericidal substance in the fibres of the fabric and/or in a coating on the inside surface of the cover, the pathogens can be controlled and the infection confined.As a result, conventional washing of the outer surface or autoclaving of a mattress or pillow cover in accordance with the invention will enable crossinfection to be totally controlled. Another important advantage is that since the bacteriostat or bactericidal substance is contained within the fabric or in a coating on the inner surface, removal of the bacteriostat or bactericidal substance by surface abrasion or topical washing is much reduced since it is protected within the fabric or in the inner coating. Furthermore, incorporation of the anti-microbial agent within the cover or in a coating on its inner surface reduces the incidence of an allergic reaction arising from contact with the anti-microbial agent.
While a variety of anti-microbial substances may be employed for incorporation into the fibres, it is advantageous to select anti-microbial substances which are substantive to the fibres, and are therefore resistant to removal by laundering. One type of preferred biocidal fibres are ones in which an inorganic bacteriostat such as zinc oxide and/or silver oxide is incorporated in the fibre during its manufacture. Preferably, the biocidal agent is incorporated in the fibre with a zeolite, which is believed to assist in firmly attaching the biocidal agent to the fibre. Zeolites are hydrated alkali aluminium silicates having a highly porous structure.
Other suitable bacteriostat or bactericidal materials, especially for incorporation in a coating on the inner surface of the cover, include a trialkyl tin sulphosalicylate or N-trichloromethylthio- 4-cyclohexene-1,2-dicarboximide, (available from R.T.
Vanderbuilt Inc. of Norwalk, Conn, U.S.A., under the trade mark Vancide). Other bacteriostat or bactericidal substances include hexachlorophene, chlorophenols, such as 6-chloro-2-phenyl phenol and Actmer biocidal agent available from Monsanto Chemical Co.
The mattress cover may be fitted over a core comprising a block of resilient, open-celled foam such as described in British Patent Nos. 2132083 and 2105,584.
The mattress may be n "self-ventilated", in that the movement of a patient on the mattress causes water-vapour, passing into the interior through the water-vapour permeable cover to pass through the foam and to exit through a porous panel at the base, e.g. as described in
British Patent No. 1,596,157. Because the cover is watervapour permeable, such movements cause water-vapour to pass through the cover from the vicinity of the patient's body, and to pass out of the mattress through the sides or the base, e.g. through air passages formed in the foam.
It is believed that this pumping action may cause bacteria supported on droplets of moisture or dust to be carried into the mattress cover where the biocidal or anti-microbial substance neutralises the bacteria, either within the fabric or in the coating on the inner surface.
While not wishing to be bound by any particular theory, it is believed that, where present, the zeolite attracts particles of dust which are generally electrostatically charged and the zinc oxide andjor silver oxide or other biocidal agent kill the bacteria which are supported on the dust particles. In cases where bacteria are present in droplets of moisture, the water-vapour permeable material channels the bacteria through the membrane with the water vapour, whereupon the biocidal substance kills the bacteria.
The mattress core need not be of foam and may alternatively include springs or horsehair or other fibres.
Another method of enhancing the bactericidal effect is to weave the biocidal fibres into a fabric having a construction such that water droplets are wicked down into contact with the biocidal component of the fabric. This may involve weaving or knitting a hydrophilic fibre, e.g.
cellulosic fibres into the fabric to enhance the wicking of the water droplets. Further details of such a construction will be given hereinafter in this specification.
The term mattress cover in this specification is used in a broad sense to include not only mattress covers of the traditional kind, e.g. as described in the abovecited British Patents Nos. 1,596,157 and 2,132,083, but also the covers of inflatable mattresses) e.g. of the kind in which a mattress is divided into compartments which are subjected to alternating pressure and also inflatable sacs of low air loss beds, e.g. of the kind described in U.K.
Patents Nos. 1,341,325, 1,474,018 and European Patent No.
0,034,954. In low air loss bed sacs there is a constant flow of air through the sac which sweeps away air which is laden with water vapour and which permeates through the water-vapour permeable membrane from areas in contact with the patient. In its passage through the water-vapour permeable membrane of the sacs, bacteria are brought into contact with the biocidal components of the membrane or cover.
In the case of alternating pressure inflatable mattresses, e.g. of the kind described in British Patents
Nos. 1,595,417 and U.S. Patent No. 4,391,009, air flow is much reduced in comparison with the low air loss bed.
Nevertheless, the alternating pressure would tend to cause moisture to pass to some extent through a water-vapour permeable fabric mattress cover. Accordingly, the covers or envelopes of alternating pressure mattresses may, with advantage, be constructed in accordance with this invention.
Preferably, the biocidal fibres are a polyester, polyacrylamide or polyacrylonitrile fibre which is not hydrophobic and has sufficient temperature resistance for auto-claving. The biocidal substance is preferably supported on zeolite and incorporated in finely-divided form in the spinning solution which is fed to the spinnerette. There is no critical minimum limit for the amount of zeolite composition containing the biocidal material but, preferably, this should be not less than about 208 by weight and may be up to 50t. The concentration of the biocidal substance depends on the particular substance selected. Typically, it may be 0.5 to 5%, preferably 0.5 to 2t by weight.The biocidal fibres may be mixed with other fibres in the construction of the fabric but preferred material will contain at least 20t of biocidally active fibres. One specific example of a procedure for incorporating a biocidal substance in fibres or into film to be coated onto fabric is described in U.S. Patent No. 3, 284,395. As described in the U.S.
patent, a coating or spinning composition is prepared by adding about 5 by weight of a biocidal agent to a solution of a polymer of acrylonitrile.
As indicated above, the mattress may have a central core of foam and may be self-ventilated. However, the mattress may include forced-ventilation, e.g. generated by an air blower as described in British Patent No.
1,443,759.
The biocidally active fibres may be woven together with a base fabric which is then coated with a watervapour permeable membrane, e.g. a polyurethane coating or a silicone rubber membrane such as described in British patent No. 1,341,325. Alternatively, the fabric may be coated with a hydrophilic polymer which on curing is water-vapour permeable as described in British patent No.
2,074,093. Alternatively, the water-vapour permeable membrane may be laminated to a woven or knitted fabric containing the biocidally active substance. The fabrics may be knitted or woven. Water-vapour permeable materials which are useful in the practice of this invention have a permeability of at least about 230g/sq metre/24 hours at 370C. Fabrics having substantially higher water vapour transmission rates may be employed, e.g. having a permeability greater than 1000g/sq metre/24 hours. Permeabilities greater than 2000g/sq metre/24 hours are possible. However, the fabric should be waterproof in contact with liquid water under a hydrostatic head of at least 250 mm of water (normally 1000 mm hydrostatic pressure) for at least 30 minutes when carrying out the test described in British Patent No.
2,024,100. Water-vapour permeable fabrics are commercially available under the trade marks "cortex (from W.L. Gore & Assoc. Inc., Newark, Delaware, USA) and "Permatex (from Carrington & Dewhurst Performance
Fabrics). Currently preferred water-vapour permeable fabrics are produced by coating a woven or knitted fabric, preferably of polyamide, polyacrylic and/or polyester fibre, with a waterproof polyurethane layer. The polyurethane can be modified so that on curing it has a microporous structure through which the water-vapour may pass. Polyurethane coating materials can be modified by including a hydrophilic polymer component. Such coatings are n "chemically" porous towards water but not generally physically microporous.An example of a commercially available coating material of this kind is "Witcoflex
Staycool" supplied by Baxenden Chemical Co. of Droitwich,
Worcester, United Kingdom. This coating material is not, however, totally impermeable to bacteria and a biocidal substance may be incorporated in the coating.
In the case where a biocidal substance is incorporated in the water-vapour permeable (w.v.p.) coating, this is conveniently done by mixing it into the coating composition just prior to spreading it on the base fabric. The concentration of the biocidal agent in the coating composition may be from about 0.5 to 5% by weight, e.g. 0.5 to 2%. Any suitable coating equipment may be used, e.g. a knife coater, set to deposit a thin coating on the surface which will form the inner surface of the mattress. Of course, both sides can be coated but generally it is sufficient to coat only one. A coating weight is selected which will deposit a layer which is thinner than the base fabric. Typical coating weights are 5 to 20 g per square metre to yield a final cured w.v.p. layer of about 25 to 200 um, preferably 50 to 100 um.Curing is usually carried out by heating to about 175 C.
It is also desirable to include a fire-retardant substance into the fabric. This may be achieve by spraying the base fabric with a solution of the substance or by including it in the w.v.p. coating composition.
Examples of suitable fire-retardant substances are "Proban 210" marketed by Alright & Wilson Limited and "Pyrovatex CP" supplied by Ciba-Geigy Limited.
Especially in cases where the cover is intended for enclosing a foam plastics core or base, the fabric from which the cover is constructed is preferably a two-way stretch material. In order to conform snugly to the foam plastics base, the fabric should extend by at least 30E in the width direction and at least 108 in the length direction when measured using a 3kg load in accordance with the test described in British Patent No. 2,105,584.
The attached Figure 1 illustrates typical laminates from which covers in accordance with the present invention may be manufactured.
Referring to Figure 1, reference numeral 1 indicates a water-vapour permeable membrane which may be formed by one of the procedures described in the above cited British patents. One commercially-available water-vapour permeable film material is sold under the trade name tPlatilon". Other materials are generally available on a woven backing fabric, e.g. of polyamide or polyester. The water-vapour permeable membrane is laminated to a fabric (2) which contains the biocidal fibres. This fabric may be woven or knitted. In one embodiment a knitted terry fabric with an upstanding pile is advantageous. This is because the pile can be used to wick moisture down into the fabric for intimate contact with the biocidal fibres.
In this embodiment, the knitted terry fabric preferably has biocidal fibres forming the scaffold.
The biocidal fibres (which are normally polyester), may be used alone or blended with other fibres, e.g. of polyester, to form yarns from which the fabric is woven or knitted. The water-vapour permeable (w.v.p.) layer 1 can be laminated to the fabric 2 by calendaring the composition from which the w.v.p. layer is formed onto the biocidal fabric 2. Alternatively, the w.v.p. membrane may be preformed and then laminated to the biocidal base fabric.
Figure 2 shows diagrammatically in cross-section a cushion of a low air loss bed. The cushion is shaped to extend widthwise of the bed and arranged together with other similar cushions to form a patient supporting surface. For further details of the construction of low air loss beds, reference may he made, for example, to
British Patent No. 1,474,018 and US Patent No. 4,525,885.
an inlet 20 is provided for connection to an air supply and provision is made for air to exhaust from the cushion at one or more other points in order to create an air flow through the interior of the cushion. The resulting air change maintains a water-vapour pressure within the cushion which is less than that at the contact area between the patient and the support surface. The cushion may include a shaped foam block 18 so that when the cushion is deflated, the patient is supported on a foam base. However, we currently prefer to employ cushions without foam interiors. Reference numeral 21 indicates a strap arranged to prevent the foam block being displaced.
Figure 2A is a view on an enlarged scale of part of the membrane forming the cover of the cushion. As can be seen, the membrane comprises a close-woven fabric 30 on the outside of the cushion and an adherent w.v.p. coating 31 on the inner surface. Coating 31, in this embodiment, is microporous but as explained above, the water-vapour permeability characteristics may derive from the inclusion of hydrophilic comonomers in the polymeric coating. Anti-microbial characteristics are imparted to the membrane by including biocidal fibres in the fabric 30 and/or a bacteriostat in the polymeric coating 31.
Claims (12)
1. A mattress or cushion wherein the cover comprises a sheet material which is permeable to watervapour but substantially impermeable to liquid water, said sheet material having a bacteriostat or bactericidal substance incorporated within the material or contained in a coating on the inner surface.
2. A mattress or cushion according to claim 1 wherein the sheet material comprises a woven or knitted stretch fabric wherein at least some of the fibres are biocidally active.
3. A mattress or cushion according to claim 1 or claim 2 wherein the sheet material comprises a woven or knitted fabric which is coated on the inside with a water vapour permeable coating which contains a bacteriostat or bactericidal substance dispersed therein.
4. A mattress or cushion according to any one of the preceding claims wherein the water vapour permeability of the cover is at least 250 g/sq metre/24 hours at 370C.
5. A mattress or cushion according to any one of the preceding claims wherein the sheet material is a twoway stretch fabric.
6. A mattress or cushion according to any one of the preceding claims wherein the cover also includes a fire-retardant substance.
7. A mattress which comprises an open-cell foam base and a cover over said basle, the cover comprising a water-vapour permeable sheet material which is substantially impermeable to liquid water but has a water vapour permeability of at least 250 g/sq metre/24 hours at 370C, said sheet material incorporating a bacteriostat or bactericidal substance and/or having a biocidal coating containing a bacteriostat or bactericidal -substance on its inner surface.
8. A mattress according to claim 7 wherein the biocidal coating is a water vapour permeable polyurethane coating.
9. A mattress according to claim 7 or claim 8 wherein the cover is comprised of stretch material having an extension of at least 20t in a first direction and at least 10% in a second direction at right angles to the first as measured according to British Standard 4294 using a 3 kg load.
10. A mattress according to any one of claims 7 to 9 wherein the fabric is treated with a flame retardant prior to application of the biocidal coating.
11. A low air loss mattress comprising a plurality of inflatable air sacs arranged to provide a patient supporting surface, wherein the material of at least some of the sacs comprises a water vapour permeable fabric which is substantially impermeable to liquid water, said fabric including a bacteriostat or bactericidal substance incorporated therein and/or having a biocidal coating containing a bacteriostat or bactericidal substance on its inner surface.
12. A low air loss mattress according to claim 11 wherein the biocidal coating is a polyurethane coating having a bacteriostat or bactericidal substance dispersed therein.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909024990A GB9024990D0 (en) | 1990-11-16 | 1990-11-16 | Mattress having biocidal cover |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9124357D0 GB9124357D0 (en) | 1992-01-08 |
| GB2248774A true GB2248774A (en) | 1992-04-22 |
Family
ID=10685519
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB909024990A Pending GB9024990D0 (en) | 1990-11-16 | 1990-11-16 | Mattress having biocidal cover |
| GB9124357A Withdrawn GB2248774A (en) | 1990-11-16 | 1991-11-15 | Mattress or cushion having biocidal cover |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB909024990A Pending GB9024990D0 (en) | 1990-11-16 | 1990-11-16 | Mattress having biocidal cover |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU8877591A (en) |
| GB (2) | GB9024990D0 (en) |
| WO (1) | WO1992008397A1 (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2279565B (en) * | 1992-02-04 | 1996-06-05 | John Walker | Cover structure |
| GB2300806A (en) * | 1995-05-01 | 1996-11-20 | Tilly Christie | Liquid absorbent bedding |
| WO1997024484A1 (en) * | 1995-12-28 | 1997-07-10 | Sogilo, Naamloze Vennootschap | Covering for beds and similar items and method for its manufacture |
| ES2127683A1 (en) * | 1996-05-22 | 1999-04-16 | Betere Fab Lucia Antonio | Improvements to base/mattress assemblies for beds |
| US6196156B1 (en) * | 1997-04-15 | 2001-03-06 | Seefar Technologies, Inc. | Bedding articles possessing microbe-inhibiting properties |
| EP1192885A1 (en) * | 2000-10-02 | 2002-04-03 | The Procter & Gamble Company | Disposable moisture vapour permeable, liquid impermeable covering sheet for bedding articles containing active agents |
| EP1192886A1 (en) * | 2000-10-02 | 2002-04-03 | The Procter & Gamble Company | Disposable, moisture vapour permeable, liquid impermeable covering sheet for bedding articles having odour reduction properties |
| FR2866534A1 (en) * | 2004-02-24 | 2005-08-26 | G Et C Sa | Insulated and hygienic blanket for medical use has outer fire-resistant cover of polymer-coated fabric and inner layer of insulating fibres |
| EP1915978A1 (en) * | 2006-10-26 | 2008-04-30 | Hill-Rom Industries S.A. | Device and method for regulating the humidity on the surface of a mattress-type support element |
| ITVE20080082A1 (en) * | 2008-11-11 | 2010-05-11 | Noble Biomaterials Europ Srl | PROCEDURE FOR REALIZING AN ANTIBACTERIAL PADDING AND PRODUCT SO OBTAINED. |
| WO2011067720A1 (en) | 2009-12-01 | 2011-06-09 | Gabriele Zecca | System for receiving a user |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1686854A4 (en) | 2003-11-26 | 2012-04-18 | Lanxess Deutschland Gmbh | Method for controlling fungi and mites in textile substrates |
| WO2025106808A1 (en) * | 2023-11-15 | 2025-05-22 | Stryker Corporation | Cover for a patient support |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3284395A (en) * | 1965-07-26 | 1966-11-08 | Dow Chemical Co | High acrylonitrile polymer solutions containing a mixture of monochlorinated orthophenylphenols |
| GB1341325A (en) * | 1971-07-09 | 1973-12-19 | Scales J T | Inflatable support appliance |
| GB1596158A (en) * | 1977-11-08 | 1981-08-19 | Nat Res Dev | Matress covers |
| GB2105584B (en) * | 1981-07-17 | 1985-08-21 | Courtaulds Plc | Fire resistant support for the human body |
| US4525409A (en) * | 1983-09-19 | 1985-06-25 | Flexi-Mat Corporation | Nylon or polyester treated fabric for bedding |
| GB8922059D0 (en) * | 1989-09-12 | 1989-11-15 | Slumberland Medicare Limited | Support appliances |
-
1990
- 1990-11-16 GB GB909024990A patent/GB9024990D0/en active Pending
-
1991
- 1991-11-15 WO PCT/GB1991/002012 patent/WO1992008397A1/en not_active Ceased
- 1991-11-15 AU AU88775/91A patent/AU8877591A/en not_active Abandoned
- 1991-11-15 GB GB9124357A patent/GB2248774A/en not_active Withdrawn
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2279565B (en) * | 1992-02-04 | 1996-06-05 | John Walker | Cover structure |
| GB2300806A (en) * | 1995-05-01 | 1996-11-20 | Tilly Christie | Liquid absorbent bedding |
| WO1997024484A1 (en) * | 1995-12-28 | 1997-07-10 | Sogilo, Naamloze Vennootschap | Covering for beds and similar items and method for its manufacture |
| BE1009900A5 (en) * | 1995-12-28 | 1997-10-07 | Sogilo Nv | Cover article for beds and the like, and method for manufacturing same. |
| ES2113328A1 (en) * | 1995-12-28 | 1998-04-16 | Sogilo Nv | Covering for beds and similar items and method for its manufacture |
| NL1004907C2 (en) * | 1995-12-28 | 1999-01-19 | Sogilo Nv | Covering article for beds and the like, and method for manufacturing them. |
| ES2127683A1 (en) * | 1996-05-22 | 1999-04-16 | Betere Fab Lucia Antonio | Improvements to base/mattress assemblies for beds |
| US6196156B1 (en) * | 1997-04-15 | 2001-03-06 | Seefar Technologies, Inc. | Bedding articles possessing microbe-inhibiting properties |
| US6240879B1 (en) * | 1997-04-15 | 2001-06-05 | Seefar Technologies, Inc. | Amusement articles possessing microbe-inhibiting properties |
| US7137358B2 (en) | 1997-04-15 | 2006-11-21 | Seefar Technologies, Inc. | Amusement articles possessing microbe-inhibiting properties |
| EP1192886A1 (en) * | 2000-10-02 | 2002-04-03 | The Procter & Gamble Company | Disposable, moisture vapour permeable, liquid impermeable covering sheet for bedding articles having odour reduction properties |
| WO2002028237A1 (en) * | 2000-10-02 | 2002-04-11 | The Procter & Gamble Company | Disposable, moisture vapour permeable, liquid impermeable covering sheet containing active agents |
| WO2002028238A1 (en) * | 2000-10-02 | 2002-04-11 | The Procter & Gamble Company | Disposable, moisture vapour permeable, liquid impermeable covering sheet having odour reduction properties |
| EP1192885A1 (en) * | 2000-10-02 | 2002-04-03 | The Procter & Gamble Company | Disposable moisture vapour permeable, liquid impermeable covering sheet for bedding articles containing active agents |
| FR2866534A1 (en) * | 2004-02-24 | 2005-08-26 | G Et C Sa | Insulated and hygienic blanket for medical use has outer fire-resistant cover of polymer-coated fabric and inner layer of insulating fibres |
| EP1915978A1 (en) * | 2006-10-26 | 2008-04-30 | Hill-Rom Industries S.A. | Device and method for regulating the humidity on the surface of a mattress-type support element |
| FR2907646A1 (en) * | 2006-10-26 | 2008-05-02 | Hill Rom Ind S A Sa | DEVICE AND METHOD FOR CONTROLLING MOISTURE AT THE SURFACE OF A MATTRESS TYPE SUPPORT ELEMENT. |
| ITVE20080082A1 (en) * | 2008-11-11 | 2010-05-11 | Noble Biomaterials Europ Srl | PROCEDURE FOR REALIZING AN ANTIBACTERIAL PADDING AND PRODUCT SO OBTAINED. |
| WO2011067720A1 (en) | 2009-12-01 | 2011-06-09 | Gabriele Zecca | System for receiving a user |
| US9119476B2 (en) | 2009-12-01 | 2015-09-01 | Synergy Business & Finanza Societa′ A Responsabilita′ Limitata | System for receiving a user |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9024990D0 (en) | 1991-01-02 |
| AU8877591A (en) | 1992-06-11 |
| WO1992008397A1 (en) | 1992-05-29 |
| GB9124357D0 (en) | 1992-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4736467A (en) | Operating room clothing system | |
| JP3182273B2 (en) | Composite knitted fabric and method for producing the same | |
| GB2248774A (en) | Mattress or cushion having biocidal cover | |
| EP0323116B1 (en) | Bedding system | |
| CN112674940A (en) | Wound care device with fluid transfer and adhesive properties | |
| EP2517607A1 (en) | Barrier fabric | |
| HK1046022A1 (en) | Durable, comfortable, air-permeable allergen-barrier fabrics | |
| EP0820541A1 (en) | Improvements in or relating to spacer materials | |
| US20050132754A1 (en) | Anti-bacterial medical waterproof material and sheet made of the same | |
| US20230113123A1 (en) | Mask | |
| JP2000316694A (en) | Medical laminated fabric | |
| JP2000202011A (en) | Deodorizing and dehumidifying sheet | |
| KR101572423B1 (en) | Anti Birus Pillow Cover | |
| JPH09187482A (en) | Sheet for nursing | |
| EP1719437B1 (en) | An article for rest | |
| JP6918719B2 (en) | Side land for protection of middle materials | |
| JPH10323372A (en) | Nursing sheets | |
| JPH05123236A (en) | Sheets | |
| JPH0595826A (en) | Air mat material | |
| JPH07148876A (en) | Laminated woven fabric | |
| CN214188703U (en) | Antibacterial composite fabric | |
| CN215606747U (en) | Nursing pad for emergency internal medicine | |
| JPH05111513A (en) | Medical bed | |
| JPH07327783A (en) | Mat | |
| CN222346458U (en) | Anti-mite breathable pillowcase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |